Women's Health

Researchers aimed to quantify the amount of protection maternal COVID-19 boosters provide during the first 6 months of an infant’s life.

Researchers sought to find an association and prevalence of hepatitis C infection during pregnancy using data from 1998 to 2018.

Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.

In a recent study, researchers sought to determine the potential for the overdiagnosis of breast cancer after screening for women 70 years of age and older.

Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.

In a post hoc analysis of two phase 3 trials, researchers set out to determine the impact of sex on tofacitinib in terms of efficacy, safety, and time to discontinuation.

Researchers evaluated the mortality risk of patients with polycystic ovarian syndrome and the risk of death associated with disease comorbidities.

The FDA has approved the first daily oral contraceptive for the prevention of pregnancy that does not require a health care provider’s prescription.

This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in April and May, including treatment for menopausal hot flashes, Clostridioides difficile infection, suspected opioid...

The US FDA recently approved a novel treatment for moderate to severe vasomotor symptoms that are caused by menopause.